The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer
about
MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerDysregulation of ubiquitin ligases in cancerEmerging technologies for studying DNA methylation for the molecular diagnosis of cancerIdentification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular diseaseIncreased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.A seven-gene CpG-island methylation panel predicts breast cancer progressionEpigenetic changes in BRCA1-mutated familial breast cancerThe autophagy GABARAPL1 gene is epigenetically regulated in breast cancer modelsPromoter methylation of BRCA1 is associated with estrogen, progesterone and human epidermal growth factor receptor-negative tumors and the prognosis of breast cancer: A meta-analysisDNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patientsPyrosequencing quantified methylation level of BRCA1 promoter as prognostic factor for survival in breast cancer patientGenetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer.Biology and Management of Patients With Triple-Negative Breast Cancer.Is estrogen receptor negative breast cancer risk associated with a fast life history strategy?The role of BRCA status on prognosis in patients with triple-negative breast cancer.Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer.Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts.The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
P2860
Q26775086-B4923BD4-4174-453E-8FCF-FB34308D1C25Q28086796-A8B65E15-7388-4479-95B5-87EECDAA9786Q28087759-F259DA37-7588-48FE-AB6A-85D1A4EBF482Q33895047-A866B860-B54B-488B-B288-7F044F8F017EQ34489002-BF1A1D70-D088-4EBF-ACDD-9681A3C4F002Q35626799-7F82DC73-5B96-4912-B8DF-C690D92D104CQ35738660-9477D5E2-7C15-4B23-B013-875A3A135532Q35810837-B1AE5683-5C91-4E5F-8B28-9FF07A32A204Q36334551-D99F2B09-F9F4-4AE0-AA89-36C6314C287CQ37285274-666BAE0A-5C7C-40BD-B491-8615E7CA64C6Q37317308-9DA4391A-BF34-4081-ABA5-6BD96CFB0AD3Q37709387-B4579692-226C-434B-B972-2CF035E2D935Q38893074-CC326ADC-E6CF-4812-99E1-E5C8A535681FQ43083976-8001FD56-A5E5-44D7-9E94-2A13D05234EFQ47097677-DD934058-D1B1-4EE1-AFE9-38F68889FC4DQ48551091-611B92C5-A17F-4B29-A453-7383F9FA6972Q55181360-00F6B132-D7C3-4D79-909C-254AA9CED0F3Q57107038-2843EBAB-573C-4D7B-AC32-E296A80CB1E4
P2860
The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The prognostic value of BRCA1 ...... triple negative breast cancer
@ast
The prognostic value of BRCA1 ...... triple negative breast cancer
@en
The prognostic value of BRCA1 ...... triple negative breast cancer
@nl
type
label
The prognostic value of BRCA1 ...... triple negative breast cancer
@ast
The prognostic value of BRCA1 ...... triple negative breast cancer
@en
The prognostic value of BRCA1 ...... triple negative breast cancer
@nl
prefLabel
The prognostic value of BRCA1 ...... triple negative breast cancer
@ast
The prognostic value of BRCA1 ...... triple negative breast cancer
@en
The prognostic value of BRCA1 ...... triple negative breast cancer
@nl
P2093
P2860
P356
P1476
The prognostic value of BRCA1 ...... triple negative breast cancer
@en
P2093
Andrew K Godwin
Brian K Petroff
Bruce F Kimler
Geetika Sethi
Ossama W Tawfik
Roy A Jensen
Teresa A Phillips
P2860
P356
10.7243/2049-7962-3-2
P577
2014-03-01T00:00:00Z